PMID: 42483679

Investigation into the efficacy and safety profile of oral small-molecule GLP-1 receptor agonists in type 2 diabetes and obesity: a systematic review and meta-analysis.

Li Li, Shui Dianpeng, Zhang Xiong, Tan Bing, Deng Yan

Frontiers in endocrinology · 2026

Vol. 17, pp. 1854779

View on PubMedDOI

This entry links to third-party literature. For research use only.

HumansDiabetes Mellitus, Type 2ObesityGlucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsAdministration, OralRandomized Controlled Trials as TopicBlood Glucose

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.